Evidence map›Paper›PMID 30719169›Full record

ArticleJournal of Cancer2019

Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar.

Lize Wang, Jinfeng Li, Tianfeng Wang, Yuntao Xie, Zhaoqing Fan, Yingjian He, Tao Ouyang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lize WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Jinfeng LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Tianfeng WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Yuntao XieKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Zhaoqing FanKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Yingjian HeKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.
Tao OuyangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Breast Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast cancerBreast-conserving treatmentDistant disease-free survivalIpsilateral breast tumor recurrenceLocal recurrence

Identifiers

PMID30719169
PMCPMC6360427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.